Comprehensive Allelotyping of Human Renal Cell Carcinomas Using Microsatellite DNA Probes

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1995 Mar 28

PMID 7708737

Citations 19

Authors

R E Greenberg

S Howard

A Bruzel

M Bremer

A Goll

H Salazar

J J FREED

K D Tartof

Affiliations

Soon will be listed here.

Abstract

The von Hippel-Lindau locus on chromosome 3p is a tumor suppressor gene known to be involved in nonpapillary renal cell carcinoma. A previous loss of heterozygosity (LOH) study aimed at determining the allelotype of kidney tumors has indicated that in addition to 3p, chromosome arms 5q, 6q, 10q, 11q, 17p, and 19p may also harbor tumor suppressor genes. However, cytogenetic studies reveal that chromosomes 3p, 6q, 8p, 9pq, and 14q most frequently undergo karyotypic changes in renal tumors. To resolve these differences, a collection of microsatellite DNA probes has been used to scan for LOH so that 90% of individual tumor genomes were rendered informative for allele loss. The assay is capable of detecting quantitative genomic alterations in tumor cells as well. We find that LOH is most frequent for chromosome arm 3p. However, in no tumor is 3p exclusively affected. LOH for 6q, 8p, 9pq, and 14q is also distinctly elevated for both nonpapillary as well as papillary tumors and suggest that many of the tumor suppressor loci involved may be common to the etiology of both forms of kidney cancer.

Citing Articles

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.

Eichenauer T, Shadanpour N, Kluth M, Gobel C, Weidemann S, Fraune C World J Surg Oncol. 2020; 18(1):128.

PMID: 32534597 PMC: 7293794. DOI: 10.1186/s12957-020-01902-y.

Single nucleotide polymorphisms associated with colorectal cancer susceptibility and loss of heterozygosity in a Taiwanese population.

Yang C, Lu R, Lin C, Jen C, Tung C, Yang S PLoS One. 2014; 9(6):e100060.

PMID: 24968322 PMC: 4072675. DOI: 10.1371/journal.pone.0100060.

NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinoma.

Thapa R, Chen P, Cheung M, Nogusa S, Pei J, Peri S Mol Cancer Ther. 2013; 12(8):1568-78.

PMID: 23657944 PMC: 3746800. DOI: 10.1158/1535-7163.MCT-12-1010.

Anti-CD70 immunocytokines for exploitation of interferon-γ-induced RIP1-dependent necrosis in renal cell carcinoma.

Chen P, Nogusa S, Thapa R, Shaller C, Simmons H, Peri S PLoS One. 2013; 8(4):e61446.

PMID: 23613854 PMC: 3629199. DOI: 10.1371/journal.pone.0061446.

Renal cell carcinoma.

Cairns P Cancer Biomark. 2011; 9(1-6):461-73.

PMID: 22112490 PMC: 3308682. DOI: 10.3233/CBM-2011-0176.

References

Cohen A, Li F, Berg S, Marchetto D, Tsai S, Jacobs S . Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med. 1979; 301(11):592-5. DOI: 10.1056/NEJM197909133011107. View

Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P . The 1993-94 Généthon human genetic linkage map. Nat Genet. 1994; 7(2 Spec No):246-339. DOI: 10.1038/ng0694supp-246. View

Cavenee W, Dryja T, Phillips R, Benedict W, Godbout R, Gallie B . Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 1983; 305(5937):779-84. DOI: 10.1038/305779a0. View

Hino O, Kitagawa T, Sugano H . Relationship between serum and histochemical markers for hepatitis B virus and rate of viral integration in hepatocellular carcinomas in Japan. Int J Cancer. 1985; 35(1):5-10. DOI: 10.1002/ijc.2910350103. View

Pinkel D, Straume T, Gray J . Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A. 1986; 83(9):2934-8. PMC: 323421. DOI: 10.1073/pnas.83.9.2934. View

Zbar B, Brauch H, Talmadge C, Linehan M . Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature. 1987; 327(6124):721-4. DOI: 10.1038/327721a0. View

Kovacs G, Frisch S . Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res. 1989; 49(3):651-9. View

Kovacs G . Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases. Am J Pathol. 1989; 134(1):27-34. PMC: 1879563. View

Kovacs G, Wilkens L, Papp T, de Riese W . Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis. J Natl Cancer Inst. 1989; 81(7):527-30. DOI: 10.1093/jnci/81.7.527. View

10.

Fan Y, Davis L, Shows T . Mapping small DNA sequences by fluorescence in situ hybridization directly on banded metaphase chromosomes. Proc Natl Acad Sci U S A. 1990; 87(16):6223-7. PMC: 54505. DOI: 10.1073/pnas.87.16.6223. View

11.

Morita R, Ishikawa J, Tsutsumi M, Hikiji K, Tsukada Y, Kamidono S . Allelotype of renal cell carcinoma. Cancer Res. 1991; 51(3):820-3. View

12.

Presti Jr J, Rao P, Chen Q, Reuter V, Li F, Fair W . Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res. 1991; 51(5):1544-52. View

13.

Emanuel A, Szucs S, Weier H, Kovacs G . Clonal aberrations of chromosomes X, Y, 7 and 10 in normal kidney tissue of patients with renal cell tumors. Genes Chromosomes Cancer. 1992; 4(1):75-7. DOI: 10.1002/gcc.2870040110. View

14.

Elfving P, Lundgren R, Cigudosa J, Heim S, Mandahl N, Mitelman F . Trisomy 7 in nonneoplastic kidney tissue cultured with and without epidermal growth factor. Cancer Genet Cytogenet. 1992; 64(1):99-100. DOI: 10.1016/0165-4608(92)90334-5. View

15.

Latif F, Tory K, Gnarra J, Yao M, Duh F, Orcutt M . Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993; 260(5112):1317-20. DOI: 10.1126/science.8493574. View

16.

Kovacs G . Molecular cytogenetics of renal cell tumors. Adv Cancer Res. 1993; 62:89-124. DOI: 10.1016/s0065-230x(08)60316-4. View

17.

Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M . Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res. 1994; 54(11):2852-5. View

18.

Marx J . A challenge to p16 gene as a major tumor suppressor. Science. 1994; 264(5167):1846. DOI: 10.1126/science.8009205. View

19.

Gnarra J, Tory K, Weng Y, Schmidt L, Wei M, Li H . Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet. 1994; 7(1):85-90. DOI: 10.1038/ng0594-85. View

20.

Chuman L, Fine L, Cohen A, Saier Jr M . Continuous growth of proximal tubular kidney epithelial cells in hormone-supplemented serum-free medium. J Cell Biol. 1982; 94(3):506-10. PMC: 2112226. DOI: 10.1083/jcb.94.3.506. View